Led by Chang-Kuei Chung, Helixism Biotechnology Company (HBI) is creating affordable and preventative solution for cardiovascular and cerebrovascular disease. HBI is the exclusively licensed manufacturer of Helix ECP, the next generation non-invasive external counter pulsation device, which was invented by Dr. Yang and his team at Academia Sinica of Taiwan.
With its lighter, smaller, and more efficient design, Helix ECP is capable of reducing its cost and price to at least half of the current price. This potentially allows tens million of people to enhance their health condition that was difficult previously. As an early investor, Cynthes lead the raising capital, strategic partnership building, and Japan localization together with the team.
With its lighter, smaller, and more efficient design, Helix ECP is capable of reducing its cost and price to at least half of the current price. This potentially allows tens million of people to enhance their health condition that was difficult previously. As an early investor, Cynthes lead the raising capital, strategic partnership building, and Japan localization together with the team.
Led by Chang-Kuei Chung, Helixism Biotechnology Company (HBI) is creating affordable and preventative solution for cardiovascular and cerebrovascular disease. HBI is the exclusively licensed manufacturer of Helix ECP, the next generation non-invasive external counter pulsation device, which was invented by Dr. Yang and his team at Academia Sinica of Taiwan.
With its lighter, smaller, and more efficient design, Helix ECP is capable of reducing its cost and price to at least half of the current price. This potentially allows tens million of people to enhance their health condition that was difficult previously. As an early investor, Cynthes lead the raising capital, strategic partnership building, and Japan localization together with the team.
With its lighter, smaller, and more efficient design, Helix ECP is capable of reducing its cost and price to at least half of the current price. This potentially allows tens million of people to enhance their health condition that was difficult previously. As an early investor, Cynthes lead the raising capital, strategic partnership building, and Japan localization together with the team.
ZueiZuei Technology
ZueiZuei Technology, founded by former CTO and co-founder of 17LIVE, York Chou, is the new startup focused on creating community and consumer services. They have created largest Taiwan community app with specialized domain area such as medical doctors, nurses, top engineers, and etc. Gifted with creativity, top technology minds, and serial entrepreneur experience, Zueizuei aims to create another regional impact success in Asia region. As one of early investor, Cynthes advised Zueizuei on approach to work with Japan corporates and vc, in addition to introductions to various resources.
ZueiZuei Technology
ZueiZuei Technology, founded by former CTO and co-founder of 17LIVE, York Chou, is the new startup focused on creating community and consumer services. They have created largest Taiwan community app with specialized domain area such as medical doctors, nurses, top engineers, and etc. Gifted with creativity, top technology minds, and serial entrepreneur experience, Zueizuei aims to create another regional impact success in Asia region. As one of early investor, Cynthes advised Zueizuei on approach to work with Japan corporates and vc, in addition to introductions to various resources.
With the leadership of David Ma, Apollo Medical Optics ( AMO ) is changing how dermatology will examine skin cancer in the future. The patent optical technology licensed from Taiwan University, enable doctors to see cellular level images under skin at unparalleled depth and resolution. This reduces the false alarm rate of biopsies, and allow patients to avoid going through unnecessary procedures.
In another application, unlike laser beams, its energy efficiency light source allows researchers to examines cells without harming the cell structures, opening up new frontiers in medical procedures that requires highest level of quality control such as stem cells applications. Cynthes has acted as consulting to bridge AMO with largest medical players in Japan, as well as qualifying and advising on prospects from Japan.
In another application, unlike laser beams, its energy efficiency light source allows researchers to examines cells without harming the cell structures, opening up new frontiers in medical procedures that requires highest level of quality control such as stem cells applications. Cynthes has acted as consulting to bridge AMO with largest medical players in Japan, as well as qualifying and advising on prospects from Japan.
With the leadership of David Ma, Apollo Medical Optics ( AMO ) is changing how dermatology will examine skin cancer in the future. The patent optical technology licensed from Taiwan University, enable doctors to see cellular level images under skin at unparalleled depth and resolution. This reduces the false alarm rate of biopsies, and allow patients to avoid going through unnecessary procedures.
In another application, unlike laser beams, its energy efficiency light source allows researchers to examines cells without harming the cell structures, opening up new frontiers in medical procedures that requires highest level of quality control such as stem cells applications. Cynthes has acted as consulting to bridge AMO with largest medical players in Japan, as well as qualifying and advising on prospects from Japan.
In another application, unlike laser beams, its energy efficiency light source allows researchers to examines cells without harming the cell structures, opening up new frontiers in medical procedures that requires highest level of quality control such as stem cells applications. Cynthes has acted as consulting to bridge AMO with largest medical players in Japan, as well as qualifying and advising on prospects from Japan.
Cyance Biotechnology
Cyance Biotechnology
With decades of experience in multinational fish farm management, Cyance' founders have assisted clients of different scales to plan complete value chains of aquaculture through their expertise in fish farming and Taiwan's self-developed freezing technology. Cynthes is confident that their diverse experience and deep expertise will promote the virtuous cycle of fishery and power generation in Taiwan.
Cyance Biotechnology
Cyance Biotechnology
With decades of experience in multinational fish farm management, Cyance' founders have assisted clients of different scales to plan complete value chains of aquaculture through their expertise in fish farming and Taiwan's self-developed freezing technology. Cynthes is confident that their diverse experience and deep expertise will promote the virtuous cycle of fishery and power generation in Taiwan.
Blue Carbon
Blue Carbon
The Blue Carbon Project focuses on the search and cultivation of carbon capture organisms in the ocean. It is committed to discovering species of marine lives with a high carbon sequestration capacity and their growing environment. Cynthes Capital examines the economics of projects and works with universities to explore potential solutions. We continue to search for the most economical and community-friendly solutions to the global carbon problem.
Blue Carbon
Blue Carbon
The Blue Carbon Project focuses on the search and cultivation of carbon capture organisms in the ocean. It is committed to discovering species of marine lives with a high carbon sequestration capacity and their growing environment. Cynthes Capital examines the economics of projects and works with universities to explore potential solutions. We continue to search for the most economical and community-friendly solutions to the global carbon problem.
AI Cyber Security
AI Cyber Security
The founder of Cynthes Capital has led a team of startups developing AI cyber security tools to enter Japan market. This includes support and solutions in various aspects such as business development, selling to new clients, and introducing top talents. The acquisition of new clients and top talent is a challenge that many companies entering the overseas market face. Cynthes continue to enhance its capability to provide solutions to address such pain points.
AI Cyber Security
AI Cyber Security
The founder of Cynthes Capital has led a team of startups developing AI cyber security tools to enter Japan market. This includes support and solutions in various aspects such as business development, selling to new clients, and introducing top talents. The acquisition of new clients and top talent is a challenge that many companies entering the overseas market face. Cynthes continue to enhance its capability to provide solutions to address such pain points.